Ceftriaxone-Resistant Salmonella enterica Serotype Newport, France

The multidrug-resistant (MDR) Salmonella enterica serotype Newport strain that produces CMY-2 β-lactamase (Newport MDR-AmpC) was the source of sporadic cases and outbreaks in humans in France during 2000–2005. Because this strain was not detected in food animals, it was most likely introduced into F...

Descripción completa

Detalles Bibliográficos
Autores principales: Egorova, Svetlana, Timinouni, Mohammed, Demartin, Marie, Granier, Sophie A., Whichard, Jean M., Sangal, Vartul, Fabre, Laëtitia, Delauné, Aurélia, Pardos, Maria, Millemann, Yves, Espié, Emmanuelle, Achtman, Mark, Grimont, Patrick A.D., Weill, François-Xavier
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2008
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600296/
https://www.ncbi.nlm.nih.gov/pubmed/18507913
http://dx.doi.org/10.3201/eid1406.071168
Descripción
Sumario:The multidrug-resistant (MDR) Salmonella enterica serotype Newport strain that produces CMY-2 β-lactamase (Newport MDR-AmpC) was the source of sporadic cases and outbreaks in humans in France during 2000–2005. Because this strain was not detected in food animals, it was most likely introduced into France through imported food products.

Ejemplares similares